Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143. Sampson, J. H., Vlahovic, G., Sahebjam, S., Omuro, A., Baehring, J. M., Hafler, D. A., Voloschin, A., Paliwal, P., Grosso, J., Coric, V., Cloughesy, T. F., Lim, M., Reardon, D. A. AMER SOC CLINICAL ONCOLOGY. 2015
View details for DOI 10.1200/jco.2015.33.15_suppl.3010
View details for Web of Science ID 000358036900644